Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell VaccinationMassimo Di Nicola, Andrea Anichini, Anna Guidetti et al.|Clinical Cancer Research|2004Cited by 83
Immunization of Patients with Malignant Melanoma with Autologous CD34 <sup>+</sup> Cell-Derived Dendritic Cells Transduced <i>Ex Vivo</i> with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I TrialMassimo Di Nicola, Alessandro M. Gianni, Carmelo Carlo‐Stella et al.|Human Gene Therapy|2003Cited by 21